diabetes%20mellitus
DIABETES MELLITUS
Diabetes mellitus (DM) is a heterogenous metabolic disorder characterized by the presence of hyperglycemia with carbohydrate, protein and fat metabolism disturbance which results from defects in either insulin secretion or action.
Patients with DM usually present with polyuria, polydipsia and unexplained weight loss.
Type 1 DM is caused by beta cell destruction which leads to complete insulin deficiency. It may be immune mediated or idiopathic.
Patients may present with ketoacidosis or acute onset of hyperglycemia while other patients may resemble type 2 DM or symptoms of other autoimmune disorders.
Type 2 DM is the most common form of diabetes. It is secondary to defect in insulin secretion concomitant with insulin resistance.
Majority of patients are asymptomatic. Ketoacidosis is uncommon and is usually secondary to stress (eg infection).

Definition

  • A heterogenous metabolic disorder characterized by the presence of hyperglycemia with carbohydrate, protein and fat metabolism disturbance which results from defects in either insulin secretion or action or both
  • Various genetic and environmental factors can cause progressive loss of β-cell mass and/or function that manifests clinically as hyperglycemia in both type 1 and 2 diabetes mellitus
    • When hyperglycemia occurs, patients with both type 1 and 2 diabetes mellitus are at risk of developing the same complications but with different rates of occurrence as well as progression
    • Better characterization of the many paths to β-cell dysfunction is required in the identification of individualized therapies for diabetes

Signs and Symptoms

  • Patients usually present with polyuria, polydipsia and unexplained weight loss

Type 1 Diabetes Mellitus

  • Most patients present with ketoacidosis or acute onset of hyperglycemia
  • Other patients have presentation similar to type 2 diabetes mellitus
    • Patients may have late onset and slow disease progression
  • Patients may also have other autoimmune disorders (eg Graves’ disease, Hashimoto’s thyroiditis, Addison’s disease)

Type 2 Diabetes Mellitus

  • Majority of patients are asymptomatic
  • Ketoacidosis is uncommon and usually secondary to stress (eg infection)
  • Diagnosis may not be obvious until complications have appeared
    • Hyperglycemia develops gradually and during early stage, symptoms are often not severe enough for the patient to recognize
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 08 Apr 2019

About one-third of individuals who achieved remission of type 2 diabetes (T2D) after losing weight with an intensive weight management programme sustained their remission at 2 years, according to long-term results of the DiRECT* trial.

14 Aug 2019
Progressive lipolysis may be reduced via the improved antilipolytic effect in adipose tissue, which leads to a reduction in future weight loss caused by sodium-glucose cotransporter 2 inhibitors (SGLT2is) in patients with type 2 diabetes (T2D), suggests a recent study.
06 Aug 2019
Maternal prepregnancy obesity is associated with earlier age at voice break, pubic hair development, axillary hair and acne in sons, as well as with earlier age at menarche, breast development, pubic hair development, axillary hair and acne in daughters, a study has found. These associations appear to be mediated by higher childhood body mass index in sons and partly so in daughters.
15 Feb 2018
Long-term treatment with dual-release hydrocortisone (DR-HC) appears to produce favourable effects on insulin secretion and sensitivity in patients with prediabetes, according to a study. The treatment also confers benefits for metabolic and anthropometric parameters.